The production and catabollsm of very low density lipoprotein triglycerides (VLDL-TG) were determined In 11 index patients with primary hypertriglycerldemla and In their 70 first-degree relatives. In the probands the mean value for VLDL-TG production rate was twice normal, and the mean fractional catabollc rate (FCR) was reduced to 50% from normal. A similar kinetic pattern was also observed In most hypertriglyceridemic relatives. In the normotrlglycerldemlc relatives the mean values of both kinetic parameters were comparable to those of controls. No kinetic differences were observed between families with familial hypertriglycerldemla, familial combined hyperllpldemla, or genetically unclassified hypertriglyceridemia (all diagnosed by lipoprotein phenotypes). Thus, no explanation for the phenotyplc differences between the two forms of familial hyperilpoprotelnemla was found In plasma VLDL-TG metabolism. When the families were grouped according to the VLDL-TG production rate of the proband, there was no significant difference between the VLDL-TG production rates of relatives of "overproducer" probands and relatives of the probands with normal VLDL-TG production rate. In contrast, relatives of low FCR probands had significantly lower mean FCR than the relatives of probands with a normal FCR. This difference In FCR was present both In hypertriglyceridemic and normotrlglycerldemlc relatives. These results suggest that the catabollsm (llpolysls) of VLDL-TG Is under genetic control, whereas the VLDL-TG production rate Is mainly related to obesity. It Is likely that hypertriglyceridemia often develops on the basis of VLDL overproduction In individuals who have a genetically low VLDL triglyceride removal (llpolytlc) capacity.
H uman plasma endogenous triglycerides are transported mainly in very low density lipoprotein (VLDL) particles. These are synthesized in the liver and removed at extrahepatic tissues by trie lipolytic action of endothelial lipoprotein lipase. The concentration of triglycerides in plasma is dependent on the number of circulating VLDL particles rather than on the triglyceride content of each Individual VLDL particle. 1 Hypertriglyceridemia develops either when production of VLDL is increased or when VLDL removal is impaired. Both mechanisms may, in fact, operate simultaneously, making it difficult to decide which is the basic abnormality primarily responsible for the rise in VLDL concentration. 2 ' 3 ' 4 Primary hypertriglyceridemia Is known to occur in families, suggesting that there are genetic defects in the synthesis or removal of VLDL. Two common forms of familial hypertriglyceridemia have been recognized: familial hypertriglyceridemia (FHTG) and familial combined hyperiipldemla, or familial multiple-type hyperiipoproteinemia (FCHL). 5 ' 6 ' 7 In FHTG the affected family members have elevated plasma VLDL but normal or low LDL levels (phenotype IV or V), whereas in FCHL the affected Individuals show a rise of VLDL (phenotype IV or V), LDL (phenotype IIA), or both (phenotype MB). The basic genetic defect has not been identified in either of these disorders and, thus, there are, so far, no reliable markers to confirm the diagnosis in affected individuals. The composition of the VLDL particles may be somewhat different in the two conditions, 8 but not different enough to serve as a specific diagnostic marker.
Attempts have been made to find abnormalities in lipoprotein lipid or apoprotein kinetics that would characterize the two genetic disorders. 9 " 14 In both forms of familial hypertriglyceridemia, the probands showed an increased synthetic rate of VLDL triglycerides and VLDL apo B, 10 ' 11 suggesting the presence of an oversecretion of VLDL particles into plasma. In FHTG the VLDL triglyceride synthesis is relatively more increased than that of VLDL apo B, resulting in triglyceride enrichment of VLDL particles. 1011 Moreover, in FCHL the conversion of VLDL apo B to LDL apo B is increased, 11 ' 15 and, accordingly, there is an overproduction of LDL apo B. 14 In addition, the fractional removal rates of VLDL triglycerides and VLDL apo B are often decreased in both conditions. 9 -13 All previous studies on lipoprotein kinetics in the familial 217 hypertriglyceridemias have been made only in the probands; the family diagnosis was based on lipid screening of a variable number of first-degree relatives. Thus, we do not know whether there is any familial clustering of certain lipoprotein kinetic patterns or whether these are characteristic for either FHTG or FCHL. One recent study has shown that, in FCHL, the LDL apo B production rate is increased even without a rise in LDL concentration. 14 This suggests that kinetic abnormalities might also be found in those family members who have normal VLDL or LDL concentrations. In the present study, we have assessed the VLDL triglyceride kinetics in both hyperiipidemic and normolipidemic first-degree relatives of hypertriglyceridemic probands.
Methods Probands
For this study, 11 index patients with primary hypertriglyceridemia were recruited from the patient files of the Helsinki University Central Hospital. In order to be eligible, the patients had to meet the following criteria: 1) fasting serum VLDL triglyceride concentration exceeding twice 132 mg/dl (representing the 90th percentile of healthy middle-aged subjects); 2) age less than 65 years; 3) no evidence of secondary hypertriglyceridemia as documented by a negative test for urinary protein and normal levels of blood glucose, serum creatinine, transaminases, T 4 , and TSH; 4) no history of excessive use of alcohol; 5) no use of drugs influencing serum lipid levels; 6) absence of incapacitating cerebrovascular, pulmonary, or heart disease and of morbid obesity [relative body weight (RBW) < 1.75 Weal body weight (IBW)]; 16 7) presence of at least three, living, first-degree relatives willing to participate in the study.
The clinical data of the hypertriglyceridemic probands are shown in Table 1 . The age of the probands ranged from 27 to 57 years (mean 45 years). Their RBW was between 1.16 and 1.69 with an average of 1.30. Five had RBW above 1.30, but apart from one patient, the obesity was of moderate degree. The massively obese proband (HK) lost 14 kg of weight but is still hypertriglyceridemic. Nine probands had at some time received hypolipidemic drugs, but these had been discontinued for at least 6 months before the study. Three of the probands (KN, TK, and HK) were survivors of previous myocardial infarction. Four probands (KN, TK, HK, and KM) were taking B-blocking agents but none was using a diuretic.
Six healthy males with VLDL triglyceride concentrations of less than 132 mg/dl volunteered as control probands. Their ages ranged from 31 to 50 years (mean 43 years) and their RBW, from 0.85 to 1.30 (mean 1.14). These probands were accepted only after examination of their first-degree relatives (n = 30) had shown that all had normal levels of VLDL triglycerides and LDL cholesterol (see below).
Relatives
The 11 probands reported 98 living first-degree relatives (parents, siblings, or children). Of these, 11 were excluded from the study on the basis of age (less than 16 or more than 70 years old) or because they lived permanently abroad. All the remaining 87 relatives were contacted by letter or phone, and the purpose and design of the study were explained. All were invited to participate in the turnover study or, if this was not possible, to at least give a fasting blood sample for analysis of lipoproteins. A positive response was obtained from 85 relatives (98%); 70 of these came for the turnover measurement and the remaining 15 gave a blood sample. Among these, there were two parents, 66 siblings, and 17 adult children of the probands. There were 57 male and 28 female relatives between 16 and 61 years of age (mean 43 years). Their RBW ranged from 0.80 to 1.68 (mean 1.18) of IBW. Of the 85 relatives, 21 (25%) were obese (RBW>1.30). Only a few of the examined relatives used hypolipidemic drugs or other medication that might influence lipid levels. One relative had mild, type II diabetes combined with elevated serum VLDL triglyceride level (type IV). 
Definitions of Hyperllpldemla and Familial Hyperllpldemla
Trie upper limits of "normal" used in this study were 132 mg/dl (1.50 mmol • M) for VLDL triglycerides and 232 mg/dl (6.00 mmolM) for LDL cholesterol. These reference values were obtained from a large population survey (Mini-Finland Study, unpublished observations) and represented the 90th percentile values of the Finnish adult population. The family diagnosis was based on lipoprotein lipid measurements at the first visit. Familial hypertriglyceridemia was diagnosed when at least three examined members of the family (including the proband) had elevated VLDL triglyceride levels but none had hyper-LDL-cholesterolemia (phenotypes IV, V, or normal). Familial combined hyperlipidemia was defined as a condition in which at least three members of the family (including the proband) had hyperiipoproteinemia and more than one lipoprotein phenotype was present. In addition to a subject with pure hypertriglyceridemia (type IV or V), the family with FCHL had to include at least one member with elevated LDL cholesterol (type MA or IIB) but without evidence of xanthomatosis (thus excluding familial monogenic hypercholesterolemia). Families with fewer than three hyperlipldemic members (i.e., only one affected relative in addition to the proband) were labeled as genetically unclassified (GUC). By these criteria, the study families included four with FHTG, five with FCHL, and two with GUC.
Study Protocol
After giving their consent, the subjects were advised to follow their normal dietary and exercise habits until the study. All hypolipidemic drugs were discontinued for a minimum of 6 weeks before lipid analysis or turnover study. Abstinence from alcohol was requested for the day preceding the study. For each visit, the subjects were instructed to fast overnight for 12 hours. The study protocol was accepted by the Ethical Committee of Helsinki University Central Hospital.
The blood samples were taken from the antecubital vein. The serum was immediately separated by centrifugation in the cold and stored at 4°C until analyzed. If the serum appeared turbid, chylomicrons were separated by spinning the sample for 30 minutes at 18 000 rpm in a Ti 50 rotor in a Sorvall OTD 65 preparative ultracentrifuge. Thereafter, the lipoproteins were separated by sequential ultracentrtfugation for 24 hours at 40 000 rpm at solvent densities of 1.006 (VLDL) and 1.063 (LDL) g/ml. The bottom fraction of 1.063 g/ml run was taken to represent HDL. The serum and the lipoprotein fractions were analyzed for total cholesterol (Enzymatic assay kit no. 187313 from Boehringer Diagnostica, Mannheim GmbH, West Germany) and for triglycerides (Enzymatic assay kit no. 297771 from Boehringer Diagnostica).
Measurement of VLDL Triglyceride Turnover Rate
The turnover rate of VLDL triglycerides was determined by the endogenous 3 H-glycerol labelling technique 2117 by using a single-pool analysis of the radioactivity disappearance curves. At 8:00 A.M., the subjects received a bolus injection of 150 nCi of 3 H-2-glycerol (Radiochemical Centre, Amersham, England, specific activity 200 to 400 \iCU nmol) diluted in sterile 10% ethanol-saline solution. Venous blood samples were taken from the opposite arm through an indwelling catheter at 30-minute intervals up to 6 hours and at 1-hour intervals for an additional 4 hours. The subjects fasted for the first 8 hours of the experiment (until 4:00 P.M.) and then received a light, low fat dinner. Chylomicrons were removed from the serum samples as described above. Thereafter, VLDL was separated by ultracentrifugation at a solvent density of 1.006 g/ml. The surface layer containing the VLDL was separated by tube slicing, and a 200-^1 aliquot was taken for duplicate triglyceride analysis. The rest of VLDL was extracted with chloroform/methanol (2:1), the extract was washed, and the phospholipids were removed from the organic phase by absorption to silicic acid. The VLDL triglyceride radioactivity was then measured in an LKB Wallac RacBeta 1215 liquid scintillation counter by using a PPO toluene solution. The specific activity of VLDL triglyceride was plotted on semilog paper against time, and the monoexponential slope of the curve was analyzed by a disc computer to obtain the fractional removal rate. The absolute turnover rate (equal to VLDL triglyceride synthetic or production rate) was then obtained from the formula:
where k is the fractional removal rate, S is the steady-state VLDL triglyceride concentration during the experiment (mg/dl), and PV is the plasma volume assumed to be 4.5% of body weight corrected according to the method of Alexander. 18 The turnover rate was expressed as the total turnover rate per hour and the turnover rate produced per hour per kilogram of body weight.
It is well known that the transport of triglycerides in VLDL is a complex process that is not exactly described by a single-pool, kinetic model. 1920 A somewhat better estimate of the true triglyceride flux through VLDL cascade is obtained by multicompartmental analysis 19 which also includes the slow turnover pool of VLDL triglycerides omitted in the single-pool model. However, the turnover rates obtained by the multicompartment method are also approximations, since the analysis neglects the fact that triglycerides with different (and unknown) specific activities enter and leave the VLDL pool in exchange for cholesterol esters derived from liver or from the circulating lipoproteins. 20 ' 21 -** Moreover, the 48-hour sampling period needed for the multicompartment analysis requires special dietary arrangements 19 that may influence the metabolism of VLDL triglycerides. The laborious and relatively complex experimental design used in the multicompartmental method also makes it less well adapted for any large-scale epidemiologic studies. This was the major reason why we were forced to choose the "short" turnover method and the single-pool analysis for the present study on a large population of voluntary, healthy, working people.
In spite of the fact that the single-pool analysis method gives only apparent turnover rates, the results may still be useful. The validity of these estimates is supported by the relatively high, significant correlation between the kinetic parameters obtained for VLDL triglycerides from the single-pool vs. the multicompartmental analyses. 4 The VLDL triglyceride turnover rates determined by the single-pool method show also a dose correlation with corresponding VLDL apo B production rates over a wide range of VLDL concentration. 1 ' 11 Moreover, studies on the effects of different perturbations on triglyceride kinetics appear to give, in principle, equivalent results irrespective of whether a single-pool or a multicompartmental model has been used in the data analysis. In addition, the numerical values obtained by the two models for the VLDL triglyceride production and fractional catabolic rates (FCR) are similar.
Statistical Methods
The data analysis was performed with a Honeywell-Bull DPS-8 computer using the BMDP computer program (BMDP Statistical Software Incorporated, Los Angeles, California). The results are given as means ± SEM. The significance of the differences was assessed by a conventional Student's nest after the distributions were shown to be normal. Linear regression analysis was used for testing the correlations.
Results

Probands
The VLDL triglyceride kinetic data of the probands are shown in Table 2 . The concentration of VLDL triglycerides at entry ranged from 156 to 1601 mg/dl (mean 389 mg/dl) indicating that the probands had mild to severe hypertriglyceridemia. At the turnover study, the range was from 133 to 1118 mg/dl. The VLDL triglyceride production rate ranged from 9.2 to 18.1 mg • hr~1 • kg~1, and the mean value was significantly increased compared to that of the controls (p<0.001). Eight of the probands had increased absolute VLDL triglyceride production rate when the upper limit of normal was set at 1000 mg • hr 1 on the basis of the results of the control group (and in agreement with previous data from our laboratory). In these cases, the hypertriglyceridemia could be partly attributed to an overproduction of VLDL triglycerides. Five of these eight "overproduce!-" probands had RBW levels greater than 1.30. The VLDL triglyceride FCR of the probands ranged from 0.036 to 0.290 pools-hr 1 and the mean value was significantly lower (p<0.01) than the mean FCR of the control group. Six probands had FCR less than 0.200 pools-hr" 1 (lower limit of the normal range), suggesting that in these cases, an impaired lipolysis of VLDL triglycerides contributed to the development of hypertriglyceridemia. Four of the probands showed a combination of overproduction and impaired removal; these subjects also had the highest VLDL triglyceride concentrations.
The relationship between the VLDL triglyceride concentration and production rate in the probands is shown in Figure 1 . It appears that, on this basis, the probands could be divided into two groups. The first group consisted of five subjects in whom the VLDL triglyceride concentration was close to the value predicted from the production rate. In all these patients, FCR was more than 0.200 pools hr~1 and the elevated VLDL triglyceride levels could be mainly accounted for by overproduction. The probands of the second group, on the other hand, had higher VLDL triglyceride levels than expected on the basis of their production rate, suggesting that lipolysis was defective in these patients. The FCR of these patients ranged from 0.036 to 0.156. However, the mechanism of hypertriglyceridemia in the probands did not bear any relationship to the family classification of the disorder (Figure 1 ).
Relatives
Serum lipoproteins were analyzed in 85 first-degree relatives, of whom 31 (36%) had hyperiipoproteinemia (increase of VLDL triglyceride, LDL cholesterol, or both). Of the affected relatives, five had phenotype IIA, five had type MB, 19 had type IV, and two had type V. Table 3 shows the mean values of the lipoprotein lipids of the relatives. The VLDL triglyceride was increased ( p < 0.001) and the HDL cholesterol was reduced ( p < 0.001) in the relatives as compared to the values of the controls, whereas there was no significant difference between the LDL cholesterol levels of relatives and controls.
The VLDL triglyceride turnover kinetics were measured Values are means ± SEM and are given in mg/dl. To convert mg/dl units to molar units, multiply by 0.011 for trigtycerides and by 0.026 for cholesterol. *p<0.05, tP<0.01, + p<0.001 compared to controls.
In 70 relatives. In 17 of these (24%), the VLDL trigiyceride concentration was increased (> 132 mg/dl) and in 16 it was in the upper normal range (88 to 132 mg/dl). As shown by Table 4 , the hypertriglyceridemic relatives had a significantly greater VLDL trigiyceride production rate and a lower FCR than the control subjects, whereas in the normotriglyceridemic relatives both rates were comparable to those of the controls. Of the 17 hypertriglyceridemic relatives, twelve had increased VLDL trigiyceride production rate (>1000 mg-hr 1 ) and ten showed impaired catabolism of VLDL triglycerides (FCR < 0.200 pools hr" 1 ). Tables 5 and 6 show the relatives' VLDL trigiyceride production rates separated into two categories according to the production rates of the probands. The VLDL trigiyceride production rate is expressed either as an absolute turnover rate (Table 5 ) or as a turnover rate produced per kilogram of body weight (Table 6 ). It is evident that the VLDL production status of the proband was not reflected in the relatives, irrespective of their VLDL trigiyceride level. Table 7 presents the relatives' VLDL trigiyceride FCR data divided Into two groups on the basis of whether the proband had normal or decreased FCR. Unlike the absent family association of the VLDL trigiyceride production rate, the FCR revealed a familial pattern. Hypertriglyceridemic relatives of probands with reduced removal capacity of VLDL triglycerides (FCR < 0.200 pools hr 1 ) had significantly lower mean FCR than did the hypertriglyceridemic relatives of probands with normal FCR. This difference was present in normotriglyceridemic relatives with VLDL triglycerides in the upper normal range (NS, p < 0 . 1 , twotailed f test) or in the range of less than 88 mg/dl (1 mmol/l). Of the relatives of probands with normal FCR, only 12% showed impaired removal of VLDL triglycerides, whereas 27% of the examined relatives of low FCR probands also had low FCR. Thus, a relative defect in the lipolysis of VLDL triglycerides appeared to be the trait that ran in families and accounted for the familial clustering of hypertriglyceridemia.
The steady-state, VLDL trigiyceride concentrations were similar in the hypertriglyceridemic relatives of probands with low FCR and in those of probands with normal FCR (219 ± 30 vs. 201 ± 31 mg/dl, respectively). Interestingly, however, the VLDL cholesterol/triglyceride molar ratio was significantly greater in the relatives of removaldeficient probands than in relatives of probands with normal FCR (0.55 ± 0.05 vs. 0.41 ± 0.03, p<0.05). Also, the normotriglyceridemic relatives of the two groups had similar VLDL trigiyceride concentrations (67 ± 5 vs. 72 ± 6 mg/dl), but, again, the VLDL cholesterol/triglyceride molar ratio was greater among relatives with a low FCR proband as compared to those with a normal FCR proband (0.62 ±0.02 vs. 0.50 ±0.02, p<0.01). These compositional differences in VLDL suggest that, in the presence of a moderate triglyceride removal defect, the VLDL remnant particles are accumulated into plasma to a greater extent than are the less hydrolyzed (secretory) VLDL.
Kinetic Background of Hypertrlglycerldemla In Individual Families
The individual values of the VLDL triglyceride production rates in the 11 families are shown in Figure 2 . In the whole material, there was a highly significant correlation between the VLDL triglyceride concentration and production rate ( r = 0 . 5 1 , p<0.001), indicating that the rate by which VLDL particles are secreted into plasma is an important determinant of the amount of circulating VLDL. The incidence of hypertriglyceridemia at VLDL triglyceride production rates of 1000,1000 to 1500, and > 1500 mg • hr~1 was 12%, 74%, and 100%, respectively.
An overproduction of VLDL triglycerides (>1000 mg • hr 1 ) was observed in at least one member in 10 of the 11 families; the highest incidence was five of seven examined relatives (family HK). In six families, all hypertriglyceridemic subjects had greater VLDL triglyceride production rate than did their normotriglyceridemic relatives. In three families, three or more members had a VLDL triglyceride overproduction combined with a normal FCR (families HK, KN, and TK), suggesting that an abnormally high production rate was the predominant cause of hypertriglyceride- 
Tabte 4. Plasma VLDL Triglyceride Kinetic Data of Relatives and of Controls
Values are given as mg-hr~1-kg 1 . Numbers in parentheses indicate the number of subjects in each group. mia. The magnitude of the VLDL triglyceride production rate needed for the development of hypertriglyceridemia did not show any family-specific patterns. Figure 3 shows the distribution of the VLDL triglyceride FCR values in the 14 families arranged in descending order of the mean FCR. When we used the FCR value of 0.200 pools • hr~1 as a lower limit of normal, there were two families (KN and RS) in which all members had normal FCR. In three families, only one member had a subnormal FCR of VLDL triglycerides. By contrast, in five families there were three members each with a low FCR (families RK, PA, KJ, SV, and PO), suggesting that, in these families, a defect in the catabolism of VLDL triglycerides was the major factor responsible for familial hypertriglyceridemia. Yet, several members of these families had both VLDL triglyceride overproduction and impaired catabolism. One proband (KM) had hypertriglyceridemia and a markedly impaired removal, but his five examined relatives all showed completely normal FCR, normal production rate, and normal VLDL triglyceride concentration. It is, therefore, possible that this single patient had an acquired VLDL triglyceride removal defect of unknown origin.
Obesity and VLDL Triglyceride Metabolism
The distribution of RBW in individual study families is presented in Figure 4 . Obesity was a common finding only in some families but its occurrence did not show any difference between familial forms of hypertriglyceridemia. Table 8 shows the metabolic data separately for obese (RBW > 1.30) and normal weight members of the study families. The obese subjects had slightly, but not significantly, higher VLDL triglyceride concentration. The absolute production rate of VLDL triglycerides was increased by an average of 36% in the obese family members as compared to their nonobese or mildly obese relatives. However, this difference was lost when VLDL triglyceride production rate was expressed per kilogram of actual weight. Half of the subjects with VLDL triglyceride overproduction were obese (Figure 4 ). The VLDL triglyceride synthesis rate correlated significantly with RBW (r = 0.40, p<0.05). The FCR of VLDL triglycerides, on the other hand, was only slightly lower in the obese subjects compared to the nonobese individuals ( Table 8 ). The incidence of obesity among the subjects with a low FCR was 32%, which is not significantly different from the overall incidence of obesity in the study families (34%). Thus, obesity could not account for the observed familial clustering of impaired VLDL trigtyceride clearance.
VLDL Metabolism In Relation to Type of Familial Hyperllpldemla
The individual kinetic data of the FHTG and FCHL families appear in Figures 2 and 3 . The mean values for the two-family category are listed in Table 9 . There was no significant difference between the different types of families In concentration, production, or removal of VLDL triglycerides. The VLDL metabolic parameters were also similar in the hypertriglyceridemic members of each family category. Thus, genetic hyperiipoproteinemias diagnosed by phenotypic expression failed to show any specific defects in VLDL triglyceride metabolism.
Discussion
The main purpose of the present study was to determine whether the kinetics of plasma VLDL triglycerides show any specific patterns that would characterize the different genetic types of primary hypertriglyceridemia and probably distinguish FHTG from FCHL (multiple-type hypertipoproteinemia) and from nonfamilial (sporadic) hypertriglyceridemia. All previous studies carried out on VLDL triglyceride or VLDL apo B transport in FHTG and FCHL have included only the probands. 9 " 13 Moreover, the criteria used for definition of the familial hyperiipidemias have not been uniform. Dunn et al. 23 have recently reported a family where VLDL triglyceride kinetics were determined in five brothers, three of whom showed hypertriglyceridemia (type IV or V) associated with a low FCR. To our knowledge, this is the only study where VLDL kinetics have been assessed within a family.
A number of kinetic studies have shown that, in most patients with primary endogenous hypertriglyceridemia, the production rates of both VLDL triglycerides and VLDL apo B are increased. 3 ' 4i 24~ZT The production rates of VLDL triglycerides and VLDL apo B are closely intercorrelated over a wide range of VLDL concentration, 1 ' 11 suggesting that plasma triglyceride overproduction is based largely on secretion of an increased number of VLDL particles into circulation. It is known, however, that the production rates of VLDL triglycerides and VLDL apo B may show disproportionate variations, one being increased more than the other. Poapst et al. 1 have estimated that, with increasing VLDL triglyceride production, there is progressively less increase in apo B production, i.e., the ratio of VLDLtriglyceride/apo B production rate increases. In simple obesity, VLDL triglyceride and apo B productions are proportionally increased, resulting in oversecretion of VLDL particles of normal composition 28 ' a (even though the actual composition of secretory or nascent VLDL particles is not known). On the other hand, probands of families with FHTG may have a disproportionally greater overproduction of VLDL triglycerides than of VLDL apo B, 10 ' " • M resulting in triglyceride enrichment of the circulating VLDL particles. 8 ' 10 A similar increase of VLDL triglyceride production without a parallel rise of apo B production can be induced by a high carbohydrate diet. 31 An opposite change has been reported by Chait et al. 10 in probands of FCHL families who were found to have a relatively greater overproduction of VLDL apo B than of VLDL triglycerides. However, as long as family studies on the VLDL triglyceride and apo B turnovers are not available, the possible genetic basis of the differences between FHTG and FCHL remains obscure.
In the present study, the families diagnosed by lipoprotein phenotype to have FHTG failed to show any characteristic features of VLDL triglyceride kinetics that would have distinguished them from families with FCHL. This result is consistent with the findings of Stalenhoef 12 and Beil et al. 13 In these studies, as in the present one, the production rate Values are means ± SEM. FHTG = familial hypertriglyceridemia, FCHL = familial combined hyperlipidemia, GUC = genetically unclassified families, FCR = fractional catabolic rate. *p<0.05 for difference from GUC.
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of VLDL triglycerides was increased to a similar extent in patients (probands) with FCHL or FHTG. Even though the studies of both Chait et al. 1 0 3 0 and Kissebah et al. 11 suggested that probands with FHTG had a higher mean VLDL triglyceride production rate than the probands with FCHL, there was a considerable overlapping between the triglyceride turnover values of the two groups. Also, the ratio of VLDL triglyceride to apo B production rate does not sharply discriminate FHTG from FCHL or from simple obesity. 10 ' 112 s. 29 it is possible, moreover, that the small differences in the relative rates of production of VLDL components may be secondary to the overall synthetic rate of VLDL particles, as suggested by the data of Poapst et al. 1 On the other hand, it is important to realize that neither endogenous labelling of VLDL triglycerides nor incorporation of an exogenous label to circulating VLDL particles will give a reliable measure of the actual influx rate of nascent VLDL into the circulation. 32 ' M In addition, the composition and particle size distribution of VLDL, which may be characteristic for the two genetic forms of hypertriglyceridemia, 8 may ultimately depend on the rate of production and the efficiency of removal of VLDL rather than on the nature of newly secreted nascent VLDL particles.
The results of the present study showed that the only kinetic variable that definitely followed a familial pattern was the FCR of VLDL triglycerides. The relatives of low FCR probands had significantly lower mean FCR than the respective relatives of probands with a normal FCR (>0.200 pools-hr 1 ). What makes this finding particularly remarkable is the presence of the difference not only among the hypertriglyceridemic relatives, but also among the normotriglyceridemic relatives. Moreover, the incidence of low FCR was more common in family members of low FCR probands than among relatives of normal FCR probands. These results suggest that the removal of VLDL triglycerides is genetically controlled. The data do not, however, permit conclusions on the nature of the trait responsible for genetic regulation of the removal capacity. The most likely candidate is the functional (endothelial) lipoprotein lipase activity, but the composition and size of the substrate particles (VLDL and its remnants) may also influence the rate of the delipidation process.
In spite of its definite familial patterns, the FCR of VLDL triglycerides was not a specific marker for either FHTG or FCHL. In terms of applied kinetic model and family classification, the FCR did not segregate the families with FHTG, FCHL, or unclassified hypertriglyceridemia any better than did the VLDL triglyceride production rate. This failure to find any kinetic marker for the familial forms of hypertriglyceridemia suggests that the genetic defect is neither in the VLDL synthesis, in the composition of nascent VLDL particles, nor in the delipidation process. It is possible that the difference between FHTG and FCHL is somewhere in the lipolytic cascade distal to the action of lipoprotein lipase, e.g., at the conversion of IDL to LDL.
